Doctor Discussion Guide
Doctor Discussion Guide
Doctor Discussion Guide Be prepared to talk with a doctor about CPP and your child. Take our Doctor Discussion Guide with you to your pediatrician visit to help you get the answers you need.
Growth Comparison Tool
Growth Comparison Tool
Growth Comparison Tool How does your child compare to other children of the same age? Use our Growth Comparison Tool to track one observable aspect of your child's growth—his or her height.
Learn about Lupron Depot-PED
Log In

Find Out More About Lupron Depot-PED
and How It's Used to Treat Central Precocious
Puberty (CPP)

Lupron Depot-PED belongs to a class of drugs called gonadotropin-releasing hormone agonists (GnRHa). It works in children with CPP by stopping the production of certain hormones at adult levels.

Knowing more about how Lupron Depot-PED works can help you better understand your child's treatment. You can learn about the treatment in our About Lupron Depot-PED section, including how the treatment is administered by a doctor, duration of therapy, and what your child can expect during therapy.

Deciding whether Lupron Depot-PED is appropriate for your child is a decision that will need to be made with a doctor. Our Doctor Discussion Guide can help you to start a conversation with your doctor about CPP and treatment with Lupron Depot-PED.
test
    

Important Safety and Other Information:

Lupron Depot-PED (7.5 mg, 11.25 mg, and 15 mg) is used for the treatment of central precocious puberty. In clinical studies, the most frequent adverse event related to therapy with Lupron Depot-PED was an injection site reaction, seen in 5% of children in the combined studies. The recommended starting dose of Lupron Depot-PED is 0.3 mg/kg/4 weeks (minimum 7.5 mg). Inadequate dosing may result in poor control of the pubertal process.

For further information about Lupron Depot-PED, please see the complete Prescribing Information, as well as the
Patient Product Information.
  
©2005, 2008 Abbott Laboratories, Abbott Park, Illinois, U.S.A.